A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

Description

The purpose of this research study is to assess whether morning bright light therapy (BLT) using a wearable device called a Re-Timer could potentially improve Irritable Bowel Syndrome (IBS) symptoms and decrease intestinal permeability (leaky gut). Morning bright light therapy will be administrated through a safe-wearable glasses device called a Re-Timer. The Re-Timer glasses are lightweight and deliver blue-green light at 500nm, mimicking exposure to natural light.

Conditions

Irritable Bowel Syndrome (IBS), Circadian Misalignment

Study Overview

Study Details

Study overview

The purpose of this research study is to assess whether morning bright light therapy (BLT) using a wearable device called a Re-Timer could potentially improve Irritable Bowel Syndrome (IBS) symptoms and decrease intestinal permeability (leaky gut). Morning bright light therapy will be administrated through a safe-wearable glasses device called a Re-Timer. The Re-Timer glasses are lightweight and deliver blue-green light at 500nm, mimicking exposure to natural light.

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

Condition
Irritable Bowel Syndrome (IBS)
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 65 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Medical University of South Carolina,

    Caitlin Green, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

    Study Record Dates

    2025-06-30